» Articles » PMID: 35989952

Effects of Splinting and Three Injection Therapies (corticosteroid, Autologous Blood and Prolotherapy) on Pain, Grip Strength, and Functionality in Patients with Lateral Epicondylitis

Overview
Date 2022 Aug 22
PMID 35989952
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study aims to compare the efficacy of the wrist splint and the injection of corticosteroid, autologous blood, and hypertonic dextrose in the treatment of lateral epicondylitis (LE).

Patients And Methods: A total of 120 patients (43 males, 77 females; mean age: 45.7±7.7 years; range, 18 to 65 years) diagnosed with LE between December 2013 and June 2015 were included in the study and randomized into four groups. The first group was administered 20 mg methylprednisolone acetate + 2 mL 2% prilocaine, the second group 2 mL venous blood + 0.5 mL prilocaine, and the third group 2 mL 30% dextrose + 0.5 mL prilocaine injections. A second injection was administered to the third group one month later. The fourth group was recommended to use only a wrist splint. Pre-treatment and post-treatment evaluations of the patients were carried out at one and six months by the Visual Analog Scale (VAS) in terms of pain, by Patient-Rated Tennis Elbow Evaluation (PRTEE) questionnaire in terms of functional level, and by the Jamar dynamometer in terms of grip strength.

Results: In all groups, VAS values at one and six months after treatment were found to be lower in comparison to baseline. Except for the splint group, a significant improvement was observed in all three injection groups in terms of grip strength and PRTEE values at six months compared to the baseline values. In the comparison of the groups, no significant difference was observed in terms of improvement in VAS scores and grip strength. While corticosteroid injection was significantly effective in terms of PRTEE pain, function, and total scores only at one month, the autologous injection was effective in terms of PRTEE function and total scores at only six months after treatment. There were no significant differences for splint and prolotherapy groups in terms of PRTEE scores.

Conclusion: Corticosteroid injection, autologous blood injection, and prolotherapy are effective and safe long-term methods in LE treatment.

Citing Articles

Comparing autologous blood, corticosteroid, and a combined injection of both for treating lateral epicondylitis: a randomized clinical trial.

Cakar A, Gozlu O J Orthop Traumatol. 2024; 25(1):34.

PMID: 38963583 PMC: 11224188. DOI: 10.1186/s10195-024-00772-4.

References
1.
Bayat M, Raeissadat S, Mortazavian Babaki M, Rahimi-Dehgolan S . Is Dextrose Prolotherapy Superior To Corticosteroid Injection In Patients With Chronic Lateral Epicondylitis?: A Randomized Clinical Trial. Orthop Res Rev. 2019; 11:167-175. PMC: 6847986. DOI: 10.2147/ORR.S218698. View

2.
Arik H, Kose O, Guler F, Deniz G, Egerci O, Ucar M . Injection of autologous blood versus corticosteroid for lateral epicondylitis: a randomised controlled study. J Orthop Surg (Hong Kong). 2015; 22(3):333-7. DOI: 10.1177/230949901402200313. View

3.
Altan L, Kanat E . Conservative treatment of lateral epicondylitis: comparison of two different orthotic devices. Clin Rheumatol. 2008; 27(8):1015-9. DOI: 10.1007/s10067-008-0862-8. View

4.
de Vos R, van Veldhoven P, Moen M, Weir A, Tol J, Maffulli N . Autologous growth factor injections in chronic tendinopathy: a systematic review. Br Med Bull. 2010; 95:63-77. DOI: 10.1093/bmb/ldq006. View

5.
Loftus M, Endo Y, Adler R . Retrospective analysis of postinjection ultrasound imaging after platelet-rich plasma or autologous blood: observational review of anatomic distribution of injected material. AJR Am J Roentgenol. 2012; 199(4):W501-5. DOI: 10.2214/AJR.11.8075. View